Hypertension-resistant

Study

We are currently recruiting participants for a clinical research study for adults with difficulty-to-control high blood pressure (resistant hypertension).

The main aim of PRECISION, a global Phase 3 clinical study, is to measure the effectiveness and safety of aprocitentan, an investigational medication, in treating a large number of patients with difficult-to-control high blood pressure (resistant hypertension).

You may be eligible if:

  • You are between 18 years old and older
  • Can not control your high blood pressure

Participants who are eligible will be followed by a dedicated medical team and may receive a compensation for their travel expenses.

I want to apply to this clinical study

Sherbrooke

For more information, contact us at 819 346-2887 (Sherbrooke) or at 1-844-739-3439 (toll free), or fill the online form.

The study process in pictures

Explanation

Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.

Meeting

Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.

Decision

Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.

Tests

Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.

Departure

Step 5 | If you are eligible, you may then begin a clinical study with us.